Page last updated: 2024-08-23

etoposide and Brain Stem Neoplasms, Primary

etoposide has been researched along with Brain Stem Neoplasms, Primary in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (73.33)29.6817
2010's3 (20.00)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Bendau, E; Bruce, JN; Canoll, P; Englander, ZK; Feldstein, NA; Jan, CI; Konofagou, EE; McQuillan, NM; Pouliopoulos, AN; Spinazzi, EF; Tazhibi, M; Upadhyayula, P; Wang, TJC; Wei, HJ; Wu, CC; Yoh, N; Zacharoulis, S1
Garami, M; Hauser, P; Pócza, T; Schuler, D; Vancsó, I1
Arola, M; Clausen, N; Harila-Saari, A; Holm, S; Kivivuori, SM; Lähteenmäki, P; Lannering, B; Lönnqvist, T; Porkholm, M; Riikonen, P; Saarinen-Pihkala, UM; Schomerus, E; Sehested, A; Thomassen, H; Thorarinsdottir, HK; Valanne, L; Wojcik, D1
Fujii, M; Ito, M; Natsume, A; Ohno, M; Wakabayashi, T1
Heianna, J; Maruya, J; Minakawa, T; Miyauchi, T; Narita, E; Nishimaki, K1
Kivivuori, SM; Lönnqvist, T; Riikonen, P; Saarinen-Pihkala, UM; Valanne, L1
Berger, MS; Boyett, JM; Bruggers, CS; Bruner, JM; Chan, KW; Dusenbery, KE; Ettinger, LJ; Fitz, CR; Holmes, E; Jennings, MT; Lafond, D; Mandelbaum, DE; Massey, V; McGuire, W; McNeely, L; Moulton, T; Pollack, IF; Shen, V; Sposto, R; Vezina, LG1
Bernstein, M; Blaney, S; Chen, Z; Fisher, PG; Freeman, C; Friedman, H; Greenberg, ML; Hershon, L; Korones, DN; Kretschmar, C; Zhou, T1
Bruns, PK; Daman, M; Doolittle, ND; Fortin, D; Hall, WA; Muldoon, L; Neuwelt, EA1
Benesch, M; Berthold, F; Gnekow, AK; Kortmann, RD; Pietsch, T; Rutkowski, S; Sträter, R; Wagner, S; Warmuth-Metz, M; Wolff, JE1
Classen, CF; Papke, K; Trotter, A; Wagner, S; Warmuth-Metz, M; Wolff, JE1
Chen, Z; Fisher, PG; Freeman, C; Kepner, J; Korones, DN; Kretschmar, C; Zhou, T1
Lau, CP; Leung, WK1
Gnekow, A; Kortmann, RD; Kuehl, J; Mölenkamp, G; Pietsch, T; Westphal, S; Wolff, JE1
Dieckmann, K; Schuller, E; Seidl, R; Slavc, I; Wandl, C1

Trials

4 trial(s) available for etoposide and Brain Stem Neoplasms, Primary

ArticleYear
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-15, Volume: 20, Issue:16

    Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Male; Neoadjuvant Therapy; Survival Rate; Vincristine

2002
Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.
    Pediatric blood & cancer, 2005, Oct-15, Volume: 45, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease Progression; Dose Fractionation, Radiation; Etoposide; Glioma; Humans; Radiotherapy Dosage; Vincristine

2005
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:2

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Combined Modality Therapy; Etoposide; Glioma; Humans; Radiotherapy; Survival Rate; Treatment Outcome; Vincristine

2008
Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme.
    Cancer, 2000, Nov-15, Volume: 89, Issue:10

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Glioblastoma; Humans; Male; Pilot Projects; Postoperative Care; Supratentorial Neoplasms; Survival Analysis; Treatment Outcome

2000

Other Studies

11 other study(ies) available for etoposide and Brain Stem Neoplasms, Primary

ArticleYear
Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model.
    Scientific reports, 2021, 03-22, Volume: 11, Issue:1

    Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain Stem; Brain Stem Neoplasms; Disease Models, Animal; Drug Delivery Systems; Etoposide; Evans Blue; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Mice; Pons; Proto-Oncogene Proteins c-sis; PTEN Phosphohydrolase; Tumor Suppressor Protein p53; Ultrasonography

2021
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
    Magyar onkologia, 2013, Volume: 57, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow; Brain Neoplasms; Brain Stem Neoplasms; Carcinoma; Celecoxib; Cerebellar Neoplasms; Child; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Hungary; Ischemic Attack, Transient; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Optic Nerve Glioma; Pyrazoles; Quality of Life; Retrospective Studies; Sulfonamides; Thalidomide; Treatment Outcome

2013
Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Case-Control Studies; Celecoxib; Chemoradiotherapy; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Glioma; Humans; Infant; Male; Neoplasm Grading; Prognosis; Pyrazoles; Quality of Life; Remission Induction; Sulfonamides; Survival Rate; Thalidomide; Topotecan

2014
Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; DNA Methylation; Etoposide; Female; Glioma; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Nitrosourea Compounds; Retrospective Studies; Temozolomide; Treatment Outcome

2009
Primary cystic germinoma originating from the midbrain.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:6

    Topics: Adult; Antineoplastic Agents; Biopsy; Brain Stem Neoplasms; Carboplatin; Central Nervous System Cysts; Diplopia; Etoposide; Germinoma; Humans; Male; Mesencephalon; Radiotherapy; Treatment Outcome

2009
Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas.
    Acta paediatrica (Oslo, Norway : 1992), 2011, Volume: 100, Issue:1

    Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Celecoxib; Child; Child, Preschool; Disease Progression; Etoposide; Glioma; Humans; Pilot Projects; Pyrazoles; Quality of Life; Radiation-Sensitizing Agents; Sulfonamides; Survival Analysis; Thalidomide; Topotecan; Treatment Outcome

2011
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
    Journal of neuro-oncology, 2006, Volume: 77, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Delivery Systems; Etoposide; Female; Glioma; Humans; Male; Methotrexate; Osmosis; Retrospective Studies; Treatment Outcome

2006
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.
    British journal of cancer, 2006, Oct-23, Volume: 95, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Infant; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Pons; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine

2006
Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols.
    Pediatric hematology and oncology, 2006, Volume: 23, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Disease Progression; Etoposide; Fatal Outcome; Follow-Up Studies; Glioblastoma; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Remission Induction; Supratentorial Neoplasms; Time Factors; Treatment Outcome; Vincristine

2006
Caecal metastasis from a primary small-cell lung carcinoma.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2008, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Stem Neoplasms; Carboplatin; Carcinoma, Small Cell; Cecal Neoplasms; Cecum; Colonoscopy; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged

2008
Prolonged second response to cisplatin, etoposide, and ifosfamide in a child with a recurrent brainstem glioblastoma.
    Pediatric hematology and oncology, 2001, Volume: 18, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Cisplatin; Etoposide; Female; Glioblastoma; Humans; Ifosfamide; Magnetic Resonance Imaging; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Treatment Outcome

2001